You just read:

Celsion Corporation Presents Clinical and Preclinical Data for GEN-1 IL-12 Immunotherapy in Ovarian Cancer at the Molecular Medicine TRI-Conference

News provided by

Celsion Corporation

Feb 20, 2015, 08:00 ET